GlassScriptPhysician profile
Barton W Wild
NPI 1710197579
$6,540.33
in general payments reported to CMS, 2019-2025
18 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2020: $1,036 · 2021: $1,730 · 2022: $1,362 · 2023: $671 · 2024: $586 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,398.31 | 2019-2025 | Octrode, Proclaim, Eterna |
| Nevro Corp. | $183.55 | 2022-2024 | Senza |
| Stryker Corporation | $174.03 | 2022-2025 | Spinejack |
| Boston Scientific Corporation | $173.95 | 2019-2024 | |
| Si-Bone, INC. | $131.15 | 2022 | |
| Nalu Medical, INC. | $97.15 | 2021 | |
| Medtronic, INC. | $92.68 | 2022 | |
| Pacira Therapeutics, INC. | $52.19 | 2019 | |
| Pfizer INC. | $42.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.12 | 2019 | |
| Collegium Pharmaceutical, INC. | $28.55 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.45 | 2019 | |
| Almatica Pharma LLC | $22.24 | 2021 | |
| Vertical Pharmaceuticals, LLC | $20.72 | 2019 | |
| Allergan, INC. | $16.50 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15.62 | 2019 | |
| Amgen INC. | $15.11 | 2019 | |
| Abbvie INC. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Wild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.